SHENYANG, China, May 3, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its first quarter 2011 unaudited financial results after the NASDAQ stock market closes on Wednesday, May 11, 2011 at 8:00pm (US Eastern ).
Following the earnings announcement, 3SBio's senior management will host a conference call at 5:00am (US Pacific) / 8:00am (US Eastern) / 8:00pm (Beijing) on Thursday, May 12, 2011 to discuss its first quarter 2011 unaudited financial results and recent business activity. The conference call may be accessed using the dial-in numbers below:
Conference ID: 64963899
Local dial-in:China landline
852-2475-0994International toll-free dial-in:Hong Kong
1-866-519-4004International toll dial-in: 65 6723 9381
Replay- Conference ID: 64963899
A telephone replay will be available two hours after the call until May 19, 2011 at:
61-2-8235-5000United States dial-in:
1-866-214-5335WebcastA live webcast of the conference will be available on the investor relations page of 3SBio's website at http://bbs.3sbio.com/en/News/xinvestors.aspx and at http://tinyurl.com/3SBio2011Q1
A replay of the webcast will be available within one hour after the conclusion of the call.
About 3SBio Inc.3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 700 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see www.3SBio.com for more information.
Investor ContactsBo Tan
Chief Financial Officer
Email: ir@3SBio.comTom Folinsbee
Director of Investor Relations
|SOURCE 3SBio Inc.|
Copyright©2010 PR Newswire.
All rights reserved